Lista de obras - Carlos Arturo Castañeda

Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma.

artículo científico publicado en 2014

Behaviour of breast cancer molecular subtypes through tumour progression

artículo científico publicado en 2012

Breast cancer subtype and survival among Indigenous American women in Peru

artículo científico publicado en 2018

Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.

artículo científico publicado en 2018

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

artículo científico publicado en 2015

Critical review of axillary recurrence in early breast cancer

artículo científico publicado en 2018

Detection of Helicobacter pylori in gastric cancer tissue through histopathology, immunohistochemistry and real-time reverse transcription-PCR

scientific article published on 01 August 2020

Distribution of tumor-infiltrating immune cells in glioblastoma

scientific article published on 09 October 2018

Glioblastoma of pineal region: report of four cases and literature review.

artículo científico publicado en 2017

Helicobacter Pylori Detected in Tap Water of Peruvian Patients with Gastric Cancer

artículo científico publicado en 2019

Impact of pathological features of brain metastases in prognosis

scientific article published on 26 April 2018

Implication of miRNA in the diagnosis and treatment of breast cancer.

artículo científico

Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.

artículo científico publicado en 2016

Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies

artículo científico publicado en 2019

MGMT promoter methylation in Peruvian patients with glioblastoma.

artículo científico publicado en 2018

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.

artículo científico publicado en 2017

PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.

artículo científico publicado en 2014

Pazopanib: an antiangiogenic drug in perspective.

artículo científico publicado en 2009

Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors

article

Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer

artículo científico publicado en 2015

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy

artículo científico publicado en 2019

Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer.

artículo científico publicado en 2009

Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma

scientific article published on 16 February 2019

Role of undifferentiation markers and androgen receptor expression in triple-negative breast cancer

artículo científico publicado en 2019

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer.

artículo científico publicado en 2009

The implementation of the Plan Esperanza and response to the imPACT Review.

artículo científico publicado en 2017

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

artículo científico publicado en 2010

The present and future of gene profiling in breast cancer.

artículo científico publicado en 2012

Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.

artículo científico publicado en 2017

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

scientific article published on October 2016

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o

article by Maria Vittoria Dieci et al published October 2018 in Seminars in Cancer Biology

[Tuberculosis That Mimics Cancer: Cases Referred to the National Institute of Neoplastic Diseases, Lima-Peru]

artículo científico publicado en 2018

Lista de obras de Carlos Arturo Castañeda

Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma.

Behaviour of breast cancer molecular subtypes through tumour progression

Breast cancer subtype and survival among Indigenous American women in Peru

Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

Critical review of axillary recurrence in early breast cancer

Detection of Helicobacter pylori in gastric cancer tissue through histopathology, immunohistochemistry and real-time reverse transcription-PCR

Distribution of tumor-infiltrating immune cells in glioblastoma

Glioblastoma of pineal region: report of four cases and literature review.

Helicobacter Pylori Detected in Tap Water of Peruvian Patients with Gastric Cancer

Impact of pathological features of brain metastases in prognosis

Implication of miRNA in the diagnosis and treatment of breast cancer.

Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.

Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies

MGMT promoter methylation in Peruvian patients with glioblastoma.

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.

PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.

Pazopanib: an antiangiogenic drug in perspective.

Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors

Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy

Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer.

Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma

Role of undifferentiation markers and androgen receptor expression in triple-negative breast cancer

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer.

The implementation of the Plan Esperanza and response to the imPACT Review.

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

The present and future of gene profiling in breast cancer.

Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o

[Tuberculosis That Mimics Cancer: Cases Referred to the National Institute of Neoplastic Diseases, Lima-Peru]